Amarantus Bioscience Holdings, Inc. (AMBS) Starts Presentation at the 4th Annual LD Micro Conference

Amarantus BioScience Holdings, Inc. (OTC: AMBS) is a development-stage biotechnology company focusing on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases. The company is developing the Mesencephalic-Astrocyte-derived Neurotrophic Factor, a therapeutic protein for treating Parkinson’s disease; LymPro, a blood test to diagnose Alzheimer’s disease; NuroPro to diagnose neurodegenerative diseases; and BC-SeraPro to diagnose breast cancer. For more information, visit the company’s website at www.amarantus.com